Clinical trials sponsored by Ottawa Hospital Research Institute
13
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 3 1Phase 4 4Not applicable 8
Conditions studied
Recruiting trials led by Ottawa Hospital Research Institute
- Advanced Brain Imaging-TKA (fMRI-TKA)
- COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
- Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL
- Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
- Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer
- Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
- Evaluating XPERIENCE™ Advanced Surgical Irrigation
- Pancreatic Insulin Production Capacity (PIPC) - a Feasibility Study
- Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study
- TSA Techniques in Glenohumeral OA
- TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion
- TSA vs RSA in Glenohumeral Osteoarthritis
- The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
Common questions
How many trials is Ottawa Hospital Research Institute recruiting for?
Ottawa Hospital Research Institute is the lead sponsor of 13 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.